Fungal Fusion ERADICATION Solution recall
FDA recall D-0698-2026 · initiated Apr 8, 2026
Blaine Labs Inc recalled Fungal Fusion ERADICATION Solution in Apr 2026 — an FDA Class II recall (D-0698-2026) because CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Wrong strength, or it did not keep
The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 1,500 bottles
Details
- Product
- Fungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit. Contains, 1x2 oz bottle Fungal Fusion Antifungal (Miconazole Nitrate) Cream, 1x2oz bottle Fungal Fusion Antifungal Solution (25% Undecylenic Acid) and 1x1oz bottle of Fungal Fusion Eradication Antimicrobial Show Spray (isopropyl Alcohol, D-Limonene, Undecylenic Acid). Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Santa Fe Springs, CA 90670, Manufactured for Doctor's Inc
- Recalling company
- Blaine Labs Inc
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide in the USA
- Initiated
- Apr 8, 2026
- FDA report date
- Jul 8, 2026
Frequently asked
- Was Fungal Fusion ERADICATION Solution recalled?
- Blaine Labs Inc recalled Fungal Fusion ERADICATION Solution in Apr 2026 — an FDA Class II recall (D-0698-2026) because CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Fungal Fusion ERADICATION Solution recalled?
- Per the FDA enforcement record, the reason for recall D-0698-2026 was: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
- Is a recalled Fungal Fusion ERADICATION Solution dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Fungal Fusion ERADICATION Solution are affected?
- Distributed: Nationwide in the USA. The recall covers these lots — Lot BL3572, Exp 04/16/2028. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0698-2026.